Elena I. Agarkova
Elena I. Agarkova has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Mariya G. Ilchenko
National Medical Research Centre for Oncology
5 shared publications - Natalia A. Maksimova
National Medical Research Centre for Oncology
4 shared publications - Marina A. Arzamastseva
National Medical Research Center of Oncology
3 shared publications - Anna S. Egorova
National Medical Research Centre for Oncology
2 shared publications - Elena Mikhaylovna Frantsiyants
National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Irina Viktorovna Kaplieva
Rostov Research Institute of Oncology
2 shared publications
Latest Publications
- 23 January 2026
- Published by ECO-Vector LLC (Publications) in Kazan medical journal
- Vol. 107 (1) , 150-157
Granulomatous inflammation of the liver in children
Granulomatous inflammation of the liver (granulomatous hepatitis) is a rare condition characterized by granulomas within the hepatic parenchyma. It may result from infectious causes (tuberculosis and Epstein–Barr virus infection) as well as noninfectious etiologies (drug-induced liver injury and systemic diseases). Its diagnosis and management require a multidisciplinary approach. Four pediatric patients with granulomatous liver involvement underwent abdominal ultrasonography, computed tomography, magnetic resonance imaging, and liver trephine biopsy with subsequent histological and immunohistochemical examination. In addition, polymerase chain reaction and serological testing were performed to identify infectious agents. All patients demonstrated multiple focal hepatic lesions. In two of them, Epstein–Barr virus DNA was detected, and histological analysis confirmed granulomas composed of epithelioid cells and giant cells. Following biopsy and symptomatic therapy, a reduction in hepatic lesions was observed, with complete resolution documented after 3 months. Granulomatous hepatitis is frequently asymptomatic and requires comprehensive diagnostic evaluation, including liver biopsy. Treatment aimed at eliminating the underlying cause leads to a favorable outcome. Early diagnosis and timely therapy are essential to prevent progression to hepatic fibrosis and cirrhosis.
- 23 January 2026
- Published by ECO-Vector LLC (Publications) in Kazan medical journal
- Vol. 107 (1) , 150-157
Granulomatous inflammation of the liver in children
Granulomatous inflammation of the liver (granulomatous hepatitis) is a rare condition characterized by granulomas within the hepatic parenchyma. It may result from infectious causes (tuberculosis and Epstein–Barr virus infection) as well as noninfectious etiologies (drug-induced liver injury and systemic diseases). Its diagnosis and management require a multidisciplinary approach. Four pediatric patients with granulomatous liver involvement underwent abdominal ultrasonography, computed tomography, magnetic resonance imaging, and liver trephine biopsy with subsequent histological and immunohistochemical examination. In addition, polymerase chain reaction and serological testing were performed to identify infectious agents. All patients demonstrated multiple focal hepatic lesions. In two of them, Epstein–Barr virus DNA was detected, and histological analysis confirmed granulomas composed of epithelioid cells and giant cells. Following biopsy and symptomatic therapy, a reduction in hepatic lesions was observed, with complete resolution documented after 3 months. Granulomatous hepatitis is frequently asymptomatic and requires comprehensive diagnostic evaluation, including liver biopsy. Treatment aimed at eliminating the underlying cause leads to a favorable outcome. Early diagnosis and timely therapy are essential to prevent progression to hepatic fibrosis and cirrhosis.
- Open Access
- 19 February 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 52-64
Changes in the histological structure of Guerin's carcinoma in the model of tumor development on the background of diabetes mellitus
Purpose of the study. To create a model of tumor growth in the uterus in the context of diabetes mellitus (DM) and to study its morphological features. Materials and methods. The model was created using female non-linear white rats weighing 180–220 g (n = 15). Alloxan was prelim inarily injected at a dose of 150 mg/kg of weight intraperitoneally once (inducing DM). Twenty-four hours after injection, rats were anesthetized with xylazine-zolazepam, and a suspension of Guerin's carcinoma cells was transplanted into the uterine horn. Blood glucose levels, body weight, and trunk circumference were measured for two weeks. Fourteen days after transplantation, the rats were euthanized via CO₂ inhalation. The tumor affected abdominal cavity organs and uterus were then dissected, and histological sections (5–7 μm) were prepared and stained with hematoxylin and eosin staining, with a following microscopic examination. Results. At the time of tumor transplantation, the mean glucose level was 4.6 ± 0.4 mMol/L, 24 hours later it had increased to 25.4 ± 1.2 mMol/L, and it remained at this level until euthanasia. In the abdominal cavity, macroscopically, massive multinodular osseous tumor lesions of the uterus, mesentery, and internal organs were observed. Microscopically, numerous densely located cells with polymorphic hyperchromic nuclei and figures of pathological mitosis were observed, accompanied by significant vacuolization of cells that deviated from the typical characteristics of Guerin's carcinoma. Additionally, a mass of mucous elements was observed along the borders of nodules, suggestive of fringing. In the uterine tubes fused with tumor nodules, excessive mucus secretion, destruction of epithelium, and expansion of the interclavicular space were noted. Conclusion. The constructed model of orthotopic growth of Guerin's carcinoma in the rat uterus following the induction of DM by alloxan demonstrated that in a hyperglycemic environment, morphological alterations occur in both the tumor, reflecting its transition to a more aggressive mucinous low-differentiated form, and in the uterus with substantial damage to the uterine tube. Such alterations may intensify the proclivity of tumorigenesis in the uterus in the context of DM.
- 19 February 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 52-64
Open AccessChanges in the histological structure of Guerin's carcinoma in the model of tumor development on the background of diabetes mellitus
Purpose of the study. To create a model of tumor growth in the uterus in the context of diabetes mellitus (DM) and to study its morphological features. Materials and methods. The model was created using female non-linear white rats weighing 180–220 g (n = 15). Alloxan was prelim inarily injected at a dose of 150 mg/kg of weight intraperitoneally once (inducing DM). Twenty-four hours after injection, rats were anesthetized with xylazine-zolazepam, and a suspension of Guerin's carcinoma cells was transplanted into the uterine horn. Blood glucose levels, body weight, and trunk circumference were measured for two weeks. Fourteen days after transplantation, the rats were euthanized via CO₂ inhalation. The tumor affected abdominal cavity organs and uterus were then dissected, and histological sections (5–7 μm) were prepared and stained with hematoxylin and eosin staining, with a following microscopic examination. Results. At the time of tumor transplantation, the mean glucose level was 4.6 ± 0.4 mMol/L, 24 hours later it had increased to 25.4 ± 1.2 mMol/L, and it remained at this level until euthanasia. In the abdominal cavity, macroscopically, massive multinodular osseous tumor lesions of the uterus, mesentery, and internal organs were observed. Microscopically, numerous densely located cells with polymorphic hyperchromic nuclei and figures of pathological mitosis were observed, accompanied by significant vacuolization of cells that deviated from the typical characteristics of Guerin's carcinoma. Additionally, a mass of mucous elements was observed along the borders of nodules, suggestive of fringing. In the uterine tubes fused with tumor nodules, excessive mucus secretion, destruction of epithelium, and expansion of the interclavicular space were noted. Conclusion. The constructed model of orthotopic growth of Guerin's carcinoma in the rat uterus following the induction of DM by alloxan demonstrated that in a hyperglycemic environment, morphological alterations occur in both the tumor, reflecting its transition to a more aggressive mucinous low-differentiated form, and in the uterus with substantial damage to the uterine tube. Such alterations may intensify the proclivity of tumorigenesis in the uterus in the context of DM.
- 16 October 2024
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 105 (6) , 1029-1036
Malignant melanotic nerve sheath tumor
Malignant melanotic nerve sheath tumor, previously melanotic schwannoma, is a rare peripheral nerve sheath tumor composed of melanin-producing Schwann cells, often clinically misdiagnosed as melanoma. It is an uncommon neoplasm with unpredictable biological behavior and varying treatments. Despite its histologic features indicative of benignity, including a low proliferative index, its clinical course is frequently malignant, with a high local recurrence rate and metastatic potential. The distinctive characteristics of malignant melanotic nerve sheath tumor include a relatively young patient age, signs of Carney complex, and psammoma bodies within the tumor. This study presents a case of a patient with malignant melanotic nerve sheath tumor located in the neck with a recurrent clinical course who underwent two surgical procedures. Microscopic and immunohistochemical evaluation of postoperative specimens showed positivity for melanoma markers, absence of psammoma bodies, and low mitotic activity. The clinical course of the disease was malignant, with recurrence developing in the postoperative scar. Diagnosing malignant melanotic nerve sheath tumor is radiologically and pathologically challenging. Multidisciplinary collaboration among the surgeon, radiologist, and pathologist; understanding the lesion’s anatomical context; and close attention to histopathologic findings are critical for establishing an accurate diagnosis.
- 16 October 2024
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 105 (6) , 1029-1036
Malignant melanotic nerve sheath tumor
Malignant melanotic nerve sheath tumor, previously melanotic schwannoma, is a rare peripheral nerve sheath tumor composed of melanin-producing Schwann cells, often clinically misdiagnosed as melanoma. It is an uncommon neoplasm with unpredictable biological behavior and varying treatments. Despite its histologic features indicative of benignity, including a low proliferative index, its clinical course is frequently malignant, with a high local recurrence rate and metastatic potential. The distinctive characteristics of malignant melanotic nerve sheath tumor include a relatively young patient age, signs of Carney complex, and psammoma bodies within the tumor. This study presents a case of a patient with malignant melanotic nerve sheath tumor located in the neck with a recurrent clinical course who underwent two surgical procedures. Microscopic and immunohistochemical evaluation of postoperative specimens showed positivity for melanoma markers, absence of psammoma bodies, and low mitotic activity. The clinical course of the disease was malignant, with recurrence developing in the postoperative scar. Diagnosing malignant melanotic nerve sheath tumor is radiologically and pathologically challenging. Multidisciplinary collaboration among the surgeon, radiologist, and pathologist; understanding the lesion’s anatomical context; and close attention to histopathologic findings are critical for establishing an accurate diagnosis.
- Open Access
- 21 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 24-37
Age-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
Purpose of the study. Is to determine the features in the content and activity of some components of the plasminogen activation system in the blood of patients of different ages with leiomyomas (LM) and uterine corpus endometrial cancer (UCEC). Patients and methods. The study was carried out in patients with LM (n = 35) and UCEC T1a-2N0M0 (n = 56) of reproductive, perimenopausal and postmenopausal ages. Using ELISA methods, the content and activity of urokinase (u-PA), tissue plasminogen activator (t-PA), their inhibitor PAI-1, as well as the content of the soluble form of the u-PA receptor (su-PAR) were determined in the blood of patients. The Student´s test was used for statistical processing. Results. Regardless of the nature of the uterus tumor, it has been noted a significant increase in the activity and blood level of PAI-1 (up to 8 times, p < 0.01), especially pronounced in patients with UCEC of reproductive age. It was combined with the absence of changes or with a decreasing in blood level of su-PAR by more than 40 % (p < 0.05). We observed a rise of u-PA blood level without changes in one´s activity in patients with LM of perimenopausal age. And in patients with LM and UCEC of postmenopausal age an increase in u-PA blood level as well as elevation of u-PA activity (up to 3.9 times, p < 0.01–0.05) were noted. There was an increase in the calculated t-PA index (activity per unit mass) by 1.4–2.8 times (p < 0.05) in the most patients. The indicators of LM patients were characterized by the minimum value of the ratio “t-PA activity/u-PA activity in the blood” among all studied subgroups of patients. Age-related features of the researched parameters were observed more often in the cases of LM than in the cases of UCEC. The most pronounced differences between LM and UCEC were observed in patients of reproductive and postmenopausal age, characterized by stable hormonal levels. Conclusion. The participation of the plasminogen activation system in the pathogenesis of tumor lesions of the uterine body has been shown. The system’s “response” to the development of tumors in the uterus has both general characteristics and features that depend on the nature of the tumors and on the age-specific hormonal regulation of the body, which are most pronounced in postmenopausal women. The results obtained can be used in research aimed at clarifying the targets of targeted therapy for LM and UCEC in accordance with the age of patients.
- 21 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 24-37
Open AccessAge-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
Purpose of the study. Is to determine the features in the content and activity of some components of the plasminogen activation system in the blood of patients of different ages with leiomyomas (LM) and uterine corpus endometrial cancer (UCEC). Patients and methods. The study was carried out in patients with LM (n = 35) and UCEC T1a-2N0M0 (n = 56) of reproductive, perimenopausal and postmenopausal ages. Using ELISA methods, the content and activity of urokinase (u-PA), tissue plasminogen activator (t-PA), their inhibitor PAI-1, as well as the content of the soluble form of the u-PA receptor (su-PAR) were determined in the blood of patients. The Student´s test was used for statistical processing. Results. Regardless of the nature of the uterus tumor, it has been noted a significant increase in the activity and blood level of PAI-1 (up to 8 times, p < 0.01), especially pronounced in patients with UCEC of reproductive age. It was combined with the absence of changes or with a decreasing in blood level of su-PAR by more than 40 % (p < 0.05). We observed a rise of u-PA blood level without changes in one´s activity in patients with LM of perimenopausal age. And in patients with LM and UCEC of postmenopausal age an increase in u-PA blood level as well as elevation of u-PA activity (up to 3.9 times, p < 0.01–0.05) were noted. There was an increase in the calculated t-PA index (activity per unit mass) by 1.4–2.8 times (p < 0.05) in the most patients. The indicators of LM patients were characterized by the minimum value of the ratio “t-PA activity/u-PA activity in the blood” among all studied subgroups of patients. Age-related features of the researched parameters were observed more often in the cases of LM than in the cases of UCEC. The most pronounced differences between LM and UCEC were observed in patients of reproductive and postmenopausal age, characterized by stable hormonal levels. Conclusion. The participation of the plasminogen activation system in the pathogenesis of tumor lesions of the uterine body has been shown. The system’s “response” to the development of tumors in the uterus has both general characteristics and features that depend on the nature of the tumors and on the age-specific hormonal regulation of the body, which are most pronounced in postmenopausal women. The results obtained can be used in research aimed at clarifying the targets of targeted therapy for LM and UCEC in accordance with the age of patients.
- 15 August 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (4) , 688-695
Experience of simultaneous use of single-photon emission and X-ray computed tomography in cancer patients with fibrous dysplasia
Aim to present the results of using single-photon emission computed tomography combined with X-ray computed tomography in the process of diagnosing osteodestructive changes in cancer patients with a rare comorbidity fibrous dysplasia. In the consultative and diagnostic department of the Federal State Budgetary Institution National Medical Research Center of Oncology of the Ministry of Health of Russia, Rostov-on-Don, in 2021, 2 patients with fibrous dysplasia of the skull bones and synchronous oncological diseases were examined. The patients underwent a complex of diagnostic tests: spiral X-ray computed tomography of the head, chest, abdominal cavity and small pelvis, bone scintigraphy, single-photon emission computed tomography combined with X-ray computed tomography of the skeleton bones, and puncture biopsy under ultrasound control. The described clinical observations clearly demonstrate examples of a phased diagnostic oncological search in patients without pathognomonic clinical manifestations and with multiple lesions of the skull bones. An increase in diagnostic information content in the differential diagnosis of fibrous dysplasia of the skeleton bones and bone metastases is facilitated by single-photon emission computed tomography combined with X-ray computed tomography. The combination of these two hybrid technologies provides an opportunity to simultaneous determination of the volume and localization of lesions, timely conduction of differential diagnostics and, in turn, maximum optimization of the examination and management of patients in this category.
- 15 August 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (4) , 688-695
Experience of simultaneous use of single-photon emission and X-ray computed tomography in cancer patients with fibrous dysplasia
Aim to present the results of using single-photon emission computed tomography combined with X-ray computed tomography in the process of diagnosing osteodestructive changes in cancer patients with a rare comorbidity fibrous dysplasia. In the consultative and diagnostic department of the Federal State Budgetary Institution National Medical Research Center of Oncology of the Ministry of Health of Russia, Rostov-on-Don, in 2021, 2 patients with fibrous dysplasia of the skull bones and synchronous oncological diseases were examined. The patients underwent a complex of diagnostic tests: spiral X-ray computed tomography of the head, chest, abdominal cavity and small pelvis, bone scintigraphy, single-photon emission computed tomography combined with X-ray computed tomography of the skeleton bones, and puncture biopsy under ultrasound control. The described clinical observations clearly demonstrate examples of a phased diagnostic oncological search in patients without pathognomonic clinical manifestations and with multiple lesions of the skull bones. An increase in diagnostic information content in the differential diagnosis of fibrous dysplasia of the skeleton bones and bone metastases is facilitated by single-photon emission computed tomography combined with X-ray computed tomography. The combination of these two hybrid technologies provides an opportunity to simultaneous determination of the volume and localization of lesions, timely conduction of differential diagnostics and, in turn, maximum optimization of the examination and management of patients in this category.